Finance

Lists
AMBU-B:CPH
Ambu A/S
67,35 DKK
+0,37%
(+0,25) 1D
2 ოქტ, 17:00:00 GMT+2  ·   DKK
All symbols
SymbolPriceChange% Change
Generating top insights for AMBU-B...
Open
66,70 DKK
High
67,80 DKK
Low
65,50 DKK
Mkt. cap
15,77 მლრდ.
Avg. vol.
1,06 მლნ.
Volume
619,49 ათ.
52-wk high
111,80 DKK
52-wk low
56,25 DKK
Shares outstanding
234,97 მლნ.
No. of employees
5 ათ.
Open
66,70 DKK
High
67,80 DKK
Low
65,50 DKK
Mkt. cap
15,77 მლრდ.
Avg. vol.
1,06 მლნ.
Volume
619,49 ათ.
52-wk high
111,80 DKK
52-wk low
56,25 DKK
Shares outstanding
234,97 მლნ.
No. of employees
5 ათ.
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
50 წუთის წინ
Ambu finalizes buyback program: Ambu stock costs EUR 9.04
AD HOC NEWS
AD HOC NEWS
·
14 საათის წინ
Ambu stock after-hours at EUR 9.01: plus 0.45 percent
Profile
Ambu, or officially Ambu A/S, is a Danish company that develops, produces and markets single-use endoscopy solutions, diagnostic and life-supporting equipment to hospitals, private practices, and rescue services. It was founded in Denmark in 1937, as Testa Laboratorium, by German engineer Holger Hesse. The largest business areas are anesthesia, cardiology, neurology, pulmonology, urology and gastroenterology. The company's most important products are devices for artificial ventilation, single-use endoscopes and single-use electrodes for ECG tests and neurophysiological mappings. Wikipedia
About Ambu A/S
CEOBritt Meelby Jensen
Employees5,2 ათ.
Founded1937
Headquarters-
SectorMedical device
Websiteambu.com
Previous reportsAll values in DKK
Loading Previous Earnings...
Revenue
Net income
All values in DKK
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,47 მლრდ.
1,56 მლრდ.
1,57 მლრდ.
1,64 მლრდ.
Cost of goods sold
587,00 მლნ.
611,00 მლნ.
625,00 მლნ.
665,00 მლნ.
Cost of revenue
587,00 მლნ.
611,00 მლნ.
625,00 მლნ.
665,00 მლნ.
Research and development expenses
93,00 მლნ.
94,00 მლნ.
91,00 მლნ.
87,00 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
639,00 მლნ.
689,00 მლნ.
684,00 მლნ.
667,00 მლნ.
Operating expense
732,00 მლნ.
783,00 მლნ.
775,00 მლნ.
754,00 მლნ.
Total operating expenses
1,32 მლრდ.
1,39 მლრდ.
1,40 მლრდ.
1,42 მლრდ.
Operating income
147,00 მლნ.
164,00 მლნ.
173,00 მლნ.
221,00 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
150,00 მლნ.
153,00 მლნ.
157,00 მლნ.
203,00 მლნ.
EBT excluding unusual items
150,00 მლნ.
153,00 მლნ.
157,00 მლნ.
203,00 მლნ.
Income tax expense
35,00 მლნ.
35,00 მლნ.
36,00 მლნ.
47,00 მლნ.
Effective tax rate
23,33%
22,88%
22,93%
23,15%
Other operating expenses
-
-
-
-
Net income
115,00 მლნ.
118,00 მლნ.
121,00 მლნ.
156,00 მლნ.
Net profit margin
7,84%
7,57%
7,69%
9,51%
Earnings per share
0,43
0,44
0,46
0,59
Interest and investment income
17,00 მლნ.
4,00 მლნ.
3,00 მლნ.
6,00 მლნ.
Interest expense
-
-15,00 მლნ.
-19,00 მლნ.
-24,00 მლნ.
Net interest expenses
17,00 მლნ.
-11,00 მლნ.
-16,00 მლნ.
-18,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
183,00 მლნ.
261,00 მლნ.
271,00 მლნ.
321,00 მლნ.
Gain or loss from assets sale
2,00 მლნ.
-
-
-
AI content may include mistakes. Learn more
Google აპები